期刊文献+

扶正化瘀方抗大鼠肾间质纤维化的作用 被引量:8

Effects of Fuzheng Huayu Recipe in Antagonizing Rat's Renal Interstitial Fibrosis
下载PDF
导出
摘要 目的观察扶正化瘀方抗氯化汞(HgCl_2)诱导的大鼠肾间质纤维化病变的作用,并初步探讨其作用机制。方法将大鼠随机分为正常组、模型组、扶正化瘀方(FZHY)组及维生素E(VitE)组,模型组用HgCl_2 8 mg/kg灌胃9周,FZHY组(4.6 g/kg)和VitE组(100 mg/kg)分别给予相应的药物干预。检测肾功能情况(Cr和BUN),盐酸水解法检测肾组织羟脯氨酸(Hyp)含量,HE染色、Masson染色和六胺银(PASM)染色观察肾组织病理形态,Western blot观察Ⅰ型胶原(ColⅠ)、纤维连接蛋白(FN)、α-平滑肌肌动蛋白(α-SMA)的表达。结果与模型组比较,FZHY组及VitE组大鼠肾体比(双肾质量/体重)明显下降(P<0.05)、肾组织Hyp含量明显下降(P<0.05),血清Cr和BUN含量明显下降(P<0.01),肾脏纤维化程度明显减轻。其中FZHY组比VitE组轻。FZHY组和VitE组肾组织ColⅠ和FN表达均较模型组减弱(ColⅠ,P<0.05;FN,P<0.01)。FZHY组α-SMA表达较模型组减弱(P<0.01),VitE组则无明显变化(P>0.05)。结论FZHY可改善HgCl_2诱导模型大鼠的肾功能损伤,减少细胞外基质沉积,减轻肾间质纤维化病变,其作用机制与抑制肌成纤维细胞活化有关。 Objective To observe the effects of Fuzheng Huayu Recipe (FHR) on rat's renal interstitial fibrosis induced by mercuric chloride ( HgCl2 ), and to explore preliminarily its mechanism of action. Methods Rats were randomly divided into four groups: the normal group, the model group, the FHR group and the vitamine E group, the latter two were treated respectively by FHR 4.6 g/kg and vitamine E 100 mg/kg. Rats model was established by oral administration of 8 mg/kg HgCl2 for 9 weeks. Serum creatinine (Cr) and urea nitrogen (BUN) content were tested with corresponding test kits; hydroxyproline (Hyp) content in kidney was assayed with hydrochloric acid hydrolysis; renal histologic change was observed with HE, Masson and methenamine silver (PASM) staining; and collagen type Ⅰ (Col Ⅰ), as well as protein expressions of fibronectin (FN) and asmooth muscle actin (α-SMA) was determined with Western blot. Results Compared with the model group, the kidney/body weight ratio, serum levels of Cr and BUN, kidney Hyp content, and severity of renal interstitial fibrosis in the two treated groups were significantly lower ( P 〈0.05 or P 〈0.01 ), and the improvements were more significant in the FHR group than those in the vitamine E group; Coll and FN protein expression was also weaker in the two treated group (Col, P〈0.05; FN, P〈0.01 ) ; while the expression of a-SMA was lower in the FHR group (P〈0.01), but it wasn't in the vitamine E group (P〉0.05). Conclusion FHR could improve the HgCl2- induced renal function injury in rats, decrease extracellular matrix dEposition and restrain renal interstitial fibrosis, the mechanism of action might be related with its inhibitory effect on myofibroblast activation.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2010年第1期76-79,共4页 Chinese Journal of Integrated Traditional and Western Medicine
基金 上海市科委重点基础项目(No.04JC14069) 教育部新世纪优秀人才资助计划(No.NCET-04-0437) 上海市教育委员会高校E-研究院建设计划(No.E03008) 上海市重点学科建设项目部分资助(No.Y0302)
关键词 扶正化瘀方 肾间质纤维化 氯化汞 Fuzheng Huayu Recipe renal interstitial fibrosis mercuric chloride
  • 相关文献

参考文献9

  • 1Bohle A, Strutz F, Mailer G. On the pathogenesis of chronic renal failure in primary glomerulopathies [ J ]. Exp Nephrol,1994, 2(4) :205-210.
  • 2姜哲浩,刘成海,袁继丽,崔红燕,刘成.扶正化瘀方对大鼠肝脏与肾脏并存纤维化的影响[J].中国中医基础医学杂志,2007,13(7):506-508. 被引量:6
  • 3袁继丽,刘成海,张悦,姜哲浩,刘成.氯化汞诱导大鼠肾间质纤维化的脂质过氧化损伤机制研究[J].中国中西医结合肾病杂志,2008,9(5):403-407. 被引量:15
  • 4Jamall IS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues [ J ]. Anal Biochem, 1981,112(1) :70-75.
  • 5Razzaque MS, Taguehit T. Cellular and molecular events leading to renal tubulointerstitial fibrosis [ J ]. Med Electron Microsc ,2002,35 ( 2 ) :68- 80.
  • 6Liu YH. Epithelial to mesenchymal transition in renal fihrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention[ J]. J Am Soc Nephrol,2004, 15 (1):1-12.
  • 7Cao Z, Cooper ME. Role of angiotensin Ⅱ in tubulointerstitial injury[J]. Semin Nephrol,2001,21 (6):554-562.
  • 8刘平,胡义扬,刘成,徐列明,刘成海,孙克伟,胡德昌,尹有宽,周霞秋,万谟彬,蔡雄,张志清,叶军,唐宝璋,周仁兴,贺佳.扶正化瘀胶囊干预慢性乙型肝炎肝纤维化作用的多中心临床观察[J].世界科学技术-中医药现代化,2005,7(1):24-32. 被引量:21
  • 9Rastaldi MP. Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis[J]. J Nephrol, 2006, 19 (4): 407-412.

二级参考文献27

  • 1刘成,刘平,胡义杨,朱剑亮,徐列明,薛惠明.扶正祛瘀方抗肝纤维化的研究[J].中医杂志,1994,35(10):602-604. 被引量:35
  • 2病毒性肝炎防治方案(试行)[J].中华传染病杂志,1995,13(4):241-247. 被引量:1767
  • 3袁继丽,刘成海,姜哲浩,张悦,刘成.口服氯化汞对大鼠肾间质纤维化的作用[J].中国实验动物学报,2006,14(2):93-95. 被引量:10
  • 4刘平,刘成,陈高朝,胡义杨,徐列明,吕萍,杨金龙,严润民,季青,储峰.扶正化瘀319方治疗慢性乙型肝炎及其对纤维化血清学指标的影响[J].中国中西医结合杂志,1996,16(10):588-592. 被引量:65
  • 5刘平,刘成,胡义杨,朱剑亮,薛惠明,徐列明.扶正化瘀方治疗肝炎后肝硬化的临床观察[J].中国中西医结合杂志,1996,16(8):459-462. 被引量:47
  • 6LIU P, Liu C, Xu LM, et al. Effects of Fuzheng Huayu 319 recipe on liver fibrosis in chronic hepatitis B. W J of Gastroenterology, 1998, 4(4)348 ~353.
  • 7Liu P, Liu CH, Liu C ,et al. Serun Pharmacological Stady about Effcts of FuZheng Huayu Rcipe on Hepatic Stellate Cell Proliferation andCollagen Synthesis in Rats. CJIM, 1998, 4(3): 118 ~ 122.
  • 8Murawaki Y , Ikuta Y, Koda M, et al. Comparison of serum 7S fragment of type Ⅳ collagen and serum cetral triple- helix of type Ⅳ collagen for assessment of liver fibrosis in patients with chronic viral liver disease. J Hepatol, 1996, 24:148 ~ 154.
  • 9Murawaki Y , Ikuta Y, Koda M, et al. Clinical significance of serum hyaluronan in patients with chronic viral liver disease. J Gastroenterol Hepatol, 1996, 11: 459 ~ 465.
  • 10刘平 刘成.扶正化瘀319方抗肝纤维化的实验研究[A].周金黄主编.中药药理与临床研究进展[C].北京:军事医学科学出版社,1996.314—321.

共引文献38

同被引文献146

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部